Verve Therapeutics
VERV
#7327
Rank
HK$2.65 B
Marketcap
HK$29.89
Share price
-1.66%
Change (1 day)
-56.16%
Change (1 year)

EPS for Verve Therapeutics (VERV)

EPS in 2023 (TTM): -HK$24.85

According to Verve Therapeutics's latest financial reports the company's current EPS (TTM) is -HK$24.64. In 2022 the company made an earnings per share (EPS) of -HK$22.70 a decrease over its 2021 EPS that were of -HK$19.65.

EPS history for Verve Therapeutics from 2020 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-HK$24.859.46%
2022-HK$22.7015.54%
2021-HK$19.6561.32%
2020-HK$12.18